Abstract:Background: Chronic graft-versus-host disease (cGVHD) is a serious and common complication of allogeneic hematopoietic cell transplantation (alloHCT). The oral cavity is the second most common site affected by cGVHD. In 2014, the 2005 National Institutes of Health (NIH) consensus criteria were revised to address areas of controversy. The aim of this study was to evaluate the clinical characteristics of oral cGVHD using the 2014 NIH consensus criteria. Material and methods: The baseline data of oral manifestation of patients, who were diagnosed with oral cGVHD, in the first dental visit were analyzed (n=22). The oral mucosal disease was evaluated by NIH modified Oral Mucosa Rating Scale (OMRS) and Thongprasom sign score. The salivary gland disease and sclerotic disease were determined by the presence of signs and symptoms. The functional impact was assessed by the organ-specific severity score. Results: The median time from transplant to oral cGVHD diagnosis was 11.9 months. White striae with an erosive area was found in 72.7% of the patients. The mean ± SD of NIH modified OMRS was 6.1 ± 3.0. The most common and severely affected site of lichen planus-like features was buccal mucosa. Xerostomia, superficial mucocele and limited mouth opening were found in 18.2%, 9.1%, and 9.1%, respectively, of the patients. Almost all patients (90.9%) had partial limitation of oral intake. There were no significant differences in NIH modified OMRS or organ-specific severity score among the patient characteristic groups. Moreover, there was no association between the oral manifestations of cGVHD and the patient characteristics. Conclusions: The most common oral manifestation of cGVHD was white striae with an erosive area of oral mucosal disease, followed by xerostomia, superficial mucocele, and limited mouth opening. The 2014 NIH consensus criteria for diagnostic and severity assessment are informative and feasible in real-world practice.

Chronic GVHD with nail involvement as predominant presentation

Cutaneous manifestations in a patient with chronic lymphocytic leukemia involving the head, neck and distal extremities.

A case report of chronic graft-versus-host disease manifested as both atopic dermatitis-like and hypertrophic lichen planus-like lesions

Impairment of bone marrow endothelial progenitor cells in acute graft-versus-host disease patients after allotransplant.

Nail Changes as the Initial Sign of Psoriasis: A Case Report

Atopic Dermatitis–like Presentation of Graft-Versus-host Disease: A Novel Form of Chronic Cutaneous Graft-Versus-host Disease

Nail Changes as the Initial Sign of Psoriasis

The Management of Chronic Graft-Versus-Host Disease Skin Ulcers after Hematopoietic Stem Cell Transplantation: A Case Report

Multiple Oral Manifestations in a Patient With Chronic Graft Versus Host Disease: A Case Report

Oral Manifestations Of Graft-Versus-Host Disease: Report Of Two Cases.

Characterization of orofacial features in sclerodermatous chronic graft‐versus‐host disease

Clinical characteristics of oral chronic graft-versus-host disease according to the 2014 National Institutes of Health (USA) consensus criteria

Atopic dermatitis-like GVHD: clinical review of 11 cases

Alteration in the Skin Microbiome in Cutaneous Graft-Versus-Host Disease

Chronic graft-versus-host disease presenting as acute polymyositis: A case series and systematic review

Associations between acute and chronic graft-versus-host disease

Oral Manifestations Of Acute Graft-Vs-Host Disease: Case Report

Cutaneous Chronic Graft-Versus-Host Disease: Clinical Manifestations, Diagnosis, Management, and Supportive Care

Diverse macrophage populations contribute to distinct manifestations of human cutaneous graft-versus-host disease

Microvascular remodeling after autologous stem cell transplant in an overlap of systemic sclerosis and systemic lupus erythematosus: A case report

Multiple Spider Angiomas in a Patient with Chronic Hepatic Graft-Versus-host Disease